glp-1 hyperthyroidism Patients Who Lose Weight After Starting GLP-1s More Likely to See Thyroid Level Improvement GLP-1 Receptor Agonists: A Promising

We next exchanged the PPAR/ co-agonist Tesa with Lani, a PPAR// triple agonist that has previously been shown to ameliorate HFD-induced body weight gain 33,34 (Extended Data Fig

'You forget to eat': How Ozempic went from diabetes medicine to blockbuster diet drug

**Suggested Use:**

AY has given paid lectures and sat on advisory boards for the following companies with drugs used in affective and related disorders: Flow Neuroscience, Novartis, Roche, Janssen, Takeda, Noema pharma, Compass, Astrazenaca, Boehringer Ingelheim, Eli Lilly, LivaNova, Lundbeck, Sunovion, Servier, Livanova, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, Sage, Neurocentrx

NICE guidance recommends that Wegovy should be prescribed within a multidisciplinary specialist weight management service that includes dietary advice, physical activity support, and behavioural interventions